公司资料
NovoCure Limited 股价、新闻与催化剂
- 股票代码:
- NVCR
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Switzerland
股票表现
16.76 USD (-1.99%)
收盘价
最后更新: 2026年8月24日
1.83B USD
市值
股价为何变动
As of Aug 24, 2026, NVCR closed down 1.99% at $16.76. No new same-company headline was identified in the current news window.
公司概览
业务概览
NovoCure is a medical technology company focused on tumor treating fields, a non-invasive cancer treatment modality. Its business is centered on device-based oncology treatment rather than pharmaceuticals.
所在地与行业分类
NovoCure is headquartered in Switzerland and listed on NASDAQ. It sits in oncology medtech rather than biotechnology.
商业模式特征
The company depends on adoption of tumor treating fields, reimbursement, and clinical workflow integration. Investors watch usage growth, market expansion, and the breadth of oncology indications.
生物医药行业定位
NovoCure occupies a unique device-oncology niche within healthcare. It is not biotech, but it is highly relevant to cancer treatment innovation.
未来催化剂
- NovoCure’s catalysts are TTFields adoption, reimbursement, and continued execution across tumor types. The company’s stock usually responds when utilization broadens and evidence strengthens.
近期新闻
- 01
- 02
- 03
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。